185 related articles for article (PubMed ID: 17523012)
1. Enhanced oral bioavailability of piroxicam in rats by hyaluronate microspheres.
Piao MG; Kim JH; Kim JO; Lyoo WS; Lee MH; Yong CS; Choi HG
Drug Dev Ind Pharm; 2007 Apr; 33(4):485-91. PubMed ID: 17523012
[TBL] [Abstract][Full Text] [Related]
2. Development of cyclosporin A-loaded hyaluronic microsphere with enhanced oral bioavailability.
Woo JS; Piao MG; Li DX; Ryu DS; Choi JY; Kim JA; Kim JH; Jin SG; Kim DD; Lyoo WS; Yong CS; Choi HG
Int J Pharm; 2007 Dec; 345(1-2):134-41. PubMed ID: 17950545
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vivo evaluation of piroxicam-loaded gelatin microcapsule by spray drying technique.
Piao MG; Yang CW; Li DX; Kim JO; Jang KY; Yoo BK; Kim JA; Woo JS; Lyoo WS; Han SS; Lee YB; Kim DD; Yong CS; Choi HG
Biol Pharm Bull; 2008 Jun; 31(6):1284-7. PubMed ID: 18520070
[TBL] [Abstract][Full Text] [Related]
4. Solid-state dependent dissolution and oral bioavailability of piroxicam in rats.
Lust A; Laidmäe I; Palo M; Meos A; Aaltonen J; Veski P; Heinämäki J; Kogermann K
Eur J Pharm Sci; 2013 Jan; 48(1-2):47-54. PubMed ID: 23085546
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems.
Pan RN; Chen JH; Chen RR
Drug Dev Ind Pharm; 2000 Sep; 26(9):989-94. PubMed ID: 10914324
[TBL] [Abstract][Full Text] [Related]
6. Enhanced bioavailability of piroxicam via salt formation with ethanolamines.
Gwak HS; Choi JS; Choi HK
Int J Pharm; 2005 Jun; 297(1-2):156-61. PubMed ID: 15907602
[TBL] [Abstract][Full Text] [Related]
7. Novel piroxicam-loaded nanospheres generated by the electrospraying technique: physicochemical characterisation and oral bioavailability evaluation.
Mustapha O; Din FU; Kim DW; Park JH; Woo KB; Lim SJ; Youn YS; Cho KH; Rashid R; Yousaf AM; Kim JO; Yong CS; Choi HG
J Microencapsul; 2016 Jun; 33(4):323-30. PubMed ID: 27188242
[TBL] [Abstract][Full Text] [Related]
8. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique.
Li DX; Oh YK; Lim SJ; Kim JO; Yang HJ; Sung JH; Yong CS; Choi HG
Int J Pharm; 2008 May; 355(1-2):277-84. PubMed ID: 18243606
[TBL] [Abstract][Full Text] [Related]
9. Novel revaprazan-loaded gelatin microsphere with enhanced drug solubility and oral bioavailability.
Kim JS; Park JH; Jeong SC; Kim DS; Yousaf AM; Din FU; Kim JO; Yong CS; Youn YS; Oh KT; Jin SG; Choi HG
J Microencapsul; 2018 Aug; 35(5):421-427. PubMed ID: 30136606
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of spray-dried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride.
Huh Y; Cho HJ; Yoon IS; Choi MK; Kim JS; Oh E; Chung SJ; Shim CK; Kim DD
Eur J Pharm Sci; 2010 Apr; 40(1):9-15. PubMed ID: 20149868
[TBL] [Abstract][Full Text] [Related]
11. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
[TBL] [Abstract][Full Text] [Related]
12. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
Prabhu S; Ortega M; Ma C
Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
[TBL] [Abstract][Full Text] [Related]
13. Piroxicam loaded polymer hybrid microspheres based tablets with modified release kinetics: Development, characterization and in vivo evaluation.
Hamid HA; Khan S; Noor Shah SM; Asghar M; Shahid M; Hussain Z; Sohail M; Khan BA; Amin F; Jan SU; Elhissi A; Shah SMH; Minhas MU; Shah SWA; Ahmad N
Pak J Pharm Sci; 2021 Jan; 34(1(Supplementary)):327-335. PubMed ID: 34275858
[TBL] [Abstract][Full Text] [Related]
14. Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation.
Yüksel N; Karataş A; Ozkan Y; Savaşer A; Ozkan SA; Baykara T
Eur J Pharm Biopharm; 2003 Nov; 56(3):453-9. PubMed ID: 14602190
[TBL] [Abstract][Full Text] [Related]
15. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X
Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289
[TBL] [Abstract][Full Text] [Related]
16. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
17. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
18. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
[TBL] [Abstract][Full Text] [Related]
19. Fast dissolving cyclodextrin complex of piroxicam in solid dispersion part I: influence of β-CD and HPβ-CD on the dissolution rate of piroxicam.
Bouchal F; Skiba M; Chaffai N; Hallouard F; Fatmi S; Lahiani-Skiba M
Int J Pharm; 2015 Jan; 478(2):625-32. PubMed ID: 25522828
[TBL] [Abstract][Full Text] [Related]
20. Development of novel ibuprofen-loaded solid dispersion with enhanced bioavailability using cycloamylose.
Baek HH; Kim DH; Kwon SY; Rho SJ; Kim DW; Choi HG; Kim YR; Yong CS
Arch Pharm Res; 2012 Mar; 35(4):683-9. PubMed ID: 22553061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
